Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by Absci Corporation on June 4, 2026. As of the record date of April 7, 2026, there were 155,447,428 shares of common stock outstanding and entitled to vote.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and voting results.
Material Changes and Voting Results
Stockholders voted on two primary proposals:
- Proposal I (Election of Directors): Stockholders approved the election of Prof Sir Menelas Pangalos, Ph.D., and Daniel Rabinovitsj as Class II directors.
- Prof Sir Menelas Pangalos, Ph.D.: 74,118,258 votes For; 9,332,380 votes Withhold; 29,904,399 Broker Non-Votes.
- Daniel Rabinovitsj: 69,590,534 votes For; 13,860,104 votes Withhold; 29,904,399 Broker Non-Votes.
- Proposal II (Ratification of Auditors): Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
- Votes: 111,058,992 For; 2,198,390 Against; 97,655 Abstain.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, management outlook, specific risks, contingencies, or unusual items. The document serves solely to disclose the outcome of the shareholder vote.
Investor Verification Checklist
- Verify the definitive proxy statement filed on April 22, 2026, for detailed biographies of the elected directors and the rationale for the auditor selection.
- Confirm the total number of shares outstanding (155,447,428) against the latest 10-Q or 10-K filings to ensure no subsequent stock issuances or buybacks have occurred.
- Review the high volume of broker non-votes (29,904,399) for both director nominees to understand the extent of beneficial ownership held in street name without voting instructions.